Tori Rodriguez, MA, LPC, AHC

Contributing Writer https://www.infectiousdiseaseadvisor.com

Tori Rodriguez, MA, LPC, AHC, is an Atlanta-based journalist, licensed psychotherapist, and Ayurvedic health coach, creator of the body-positive wellness company Bettie Page Fitness, and author of 2 books – The Little Book of Bettie: Taking a Page from the Queen of Pinups and Bettie Page: The Lost Years. She holds a BS in psychology from Georgia State University and an MA in counseling psychology from the Georgia School of Professional Psychology. Tori has also managed a medical practice and was instrumental in developing Georgia’s multispecialty telemedicine program. Photograph courtesy of Brooklyn Brat Images.

All articles by Tori Rodriguez, MA, LPC, AHC

COVID19

COVID-19 Vaccine Mandates: Public and Expert Viewpoints

Tori Rodriguez, MA, LPC, AHC

April 23, 2021

With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.

HIV/AIDS

Women Living With HIV Require Better Mental Health Diagnostics and Interventions

Tori Rodriguez, MA, LPC, AHC

April 9, 2021

In a narrative review, researchers described various mental health interventions, and their feasibility and outcomes for WLWH.

Influenza

Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines

Tori Rodriguez, MA, LPC, AHC

March 19, 2021

An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.

COVID19

Suicide Prevention in the Context of COVID-19

Tori Rodriguez, MA, LPC, AHC

February 24, 2021

In an interview with Christine Moutier, MD, psychiatrist and chief medical officer of the American Foundation for Suicide Prevention, she speaks about how the current COVID-19 pandemic presents opportunities to improve suicide prevention efforts on multiple levels.

COVID19

Controversy: Protecting People Who Use Drugs During COVID-19

Tori Rodriguez, MA, LPC, AHC

January 25, 2021

Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.

COVID19

Expert Roundtable: Physician Burnout During COVID-19

Tori Rodriguez, MA, LPC, AHC

January 6, 2021

Monisha Sharma, PhD, and Charlene Dewey, MD, provide insight into the current landscape that leads to physician burnout and the next steps to combat it.

General Infectious Disease

Infection Risk During Targeted and Biologic Therapies in Rheumatoid Arthritis and Psoriatic Arthritis

Tori Rodriguez, MA, LPC, AHC

November 25, 2020

An overview of the risk for infections during targeted and biological therapies in rheumatoid arthritis and psoriatic arthritis.

Computer illustration of Burkitt lymphoma.

HIV/AIDS

Understanding the Oncogenic Role of HIV in Burkitt Lymphoma

Tori Rodriguez, MA, LPC, AHC

August 31, 2020

While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.

COVID19

Hepatitis B and C Virus Considerations in COVID-19

Tori Rodriguez, MA, LPC, AHC

July 15, 2020

Numerous reports have indicated gastrointestinal, cardiovascular, and neurologic manifestations, in addition to the noted respiratory effects, in patients with COVID-19, and up to 50% of patients with COVID-19 may experience hepatic manifestations.

Hepatitis Advisor

Preventing and Treating Viral Hepatitis in End-Stage Renal Disease

Tori Rodriguez, MA, LPC, AHC

May 21, 2020

Due to innate and adaptive immune alterations and the risk for nosocomial infection from exposure to potentially infected blood-borne sources, patients with end-stage renal disease (ESRD) have an elevated risk of contracting viral infections.

Next post in Hepatitis Advisor